OC-021: Biomarker results from BERIL-1: buparlisib and paclitaxel in patients with platinum-pretreated SCCHN

Autor: Soulières, D., Faivre, S., Mesía, R., Remenár, E., Li, S.H., Karpenko, A., Dechaphunkul, A., Keilholz, U., Kiss, L., Lin, J.C., Nagarkar, R., Tamás, L., Kim, S.B., Erfán, J., Alyasova, A., Yovine, A., Le Mouhaër, S., Solovieff, N., Turri, S., Licitra, L.
Zdroj: In Radiotherapy and Oncology March 2017 122 Supplement 1:14-14
Databáze: ScienceDirect